Gould Robert J

Director at FULC; Director at Epizyme, Inc.

Sold, on record
$18.1M
Dollars the filings state
Form 4 sales
34
Latest Feb 2, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale FULCUnusual
    Apr 5, 2022 2022

    Sold 94,251 shares at $24.16 ($2.3M)

    Gould Robert J, Director

    Sold 15.7% of holdings ($14.5M position)506,630 shares left33.6x usual sizeFiling

  2. 2 Form 4 sale FULCPlan not stated
    Apr 7, 2022 +2 days

    Sold 5,631 shares at $24.02 ($135k)

    Gould Robert J, Director

    Sold 1.1% of holdings ($12.3M position)506,630 shares left1.8x usual sizeFiling

  3. 3 Form 4 sale FULCUnusual
    Jun 6, 2022 +60 days

    Sold 66,622 shares at $8.00 ($533k)

    Gould Robert J, Director

    Sold 11.6% of holdings ($4.6M position)506,630 shares left14.7x usual sizeFiling

  4. 4 Form 4 sale FULCUnusual
    Jun 7, 2022 +1 day

    Sold 71,435 shares at $8.09 ($578k)

    Gould Robert J, Director

    Sold 12.4% of holdings ($4.7M position)506,630 shares left8.7x usual sizeFiling

  5. 5 Form 4 sale FULCPlan not stated
    Jan 13, 2023 +220 days

    Sold 6,766 shares at $15.00 ($101k)

    Gould Robert J, Interim President & CEO

    Sold 1.3% of holdings ($7.6M position)499,864 shares left0.7x usual sizeFiling

  6. 6 Form 4 sale FULCNo plan
    Nov 19, 2025 +1041 days

    Sold 15,000 shares at $11.03 ($165k)

    Gould Robert J, Director

    No 10b5-1 planSold 3% of holdings ($5.5M position)484,864 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale FULCNo plan
    Jan 2, 2026 +44 days

    Sold 15,000 shares at $11.87 ($178k)

    Gould Robert J, Director

    No 10b5-1 planSold 3.1% of holdings ($5.8M position)469,864 shares leftFiling

  8. 8 Form 4 sale FULCNo plan
    Feb 2, 2026 +31 days

    Sold 15,000 shares at $10.72 ($161k)

    Gould Robert J, Director

    No 10b5-1 planSold 3.2% of holdings ($5M position)454,864 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (34)

Form 144 notices and Form 4 sales by Gould Robert J
Source
Feb 2, 2026Feb 4, 2026FULCDirectorForm 4 sale15,000$161k3.2%No planSEC
Jan 2, 2026Jan 6, 2026FULCDirectorForm 4 sale15,000$178k3.1%No planSEC
Nov 19, 2025Nov 21, 2025FULCDirectorForm 4 sale15,000$165k3.0%No planSEC
Jan 13, 2023Jan 13, 2023FULCInterim President & CEOForm 4 sale6,766$101k1.3%Plan not statedSEC
Jun 7, 2022Jun 8, 2022FULCDirectorForm 4 sale71,435$578k12.4%UnusualSEC
Jun 6, 2022Jun 6, 2022FULCDirectorForm 4 sale66,622$533k11.6%UnusualSEC
Apr 7, 2022Apr 11, 2022FULCDirectorForm 4 sale5,631$135k1.1%Plan not statedSEC
Apr 5, 2022Apr 5, 2022FULCDirectorForm 4 sale94,251$2.3M15.7%UnusualSEC
Mar 16, 2021Mar 17, 2021FULCOfficer, DirectorForm 4 sale10,000$122k1.9%UnusualSEC
Feb 16, 2021Feb 18, 2021FULCOfficer, DirectorForm 4 sale8,215$117k1.6%UnusualSEC
Jan 20, 2021Jan 22, 2021FULCOfficer, DirectorForm 4 sale10,000$121k1.9%UnusualSEC
Jul 8, 2020Jul 9, 2020FULCOfficer, DirectorForm 4 sale2,500$50k0.5%Plan not statedSEC
Jun 25, 2020Jun 26, 2020FULCOfficer, DirectorForm 4 sale2,500$52k0.5%Plan not statedSEC
Jun 9, 2020Jun 10, 2020FULCOfficer, DirectorForm 4 sale156$3k0.0%Plan not statedSEC
Jun 5, 2020Jun 9, 2020FULCOfficer, DirectorForm 4 sale3,433$69k0.6%Plan not statedSEC
Jun 4, 2020Jun 5, 2020FULCOfficer, DirectorForm 4 sale2,800$56k0.5%Plan not statedSEC
Jun 2, 2020Jun 3, 2020FULCOfficer, DirectorForm 4 sale2,802$56k0.5%Plan not statedSEC
May 29, 2020Jun 1, 2020FULCOfficer, DirectorForm 4 sale3,309$66k0.6%Plan not statedSEC
May 26, 2020May 28, 2020FULCOfficer, DirectorForm 4 sale2,500$50k0.5%Plan not statedSEC
Feb 19, 2020Feb 20, 2020FULCOfficer, DirectorForm 4 sale2,500$50k0.4%Plan not statedSEC
Dec 30, 2015Dec 31, 2015Epizyme, Inc.DirectorForm 4 sale32,108$578k100.0%UnusualSEC
Sep 8, 2015Sep 10, 2015Epizyme, Inc.President & CEOForm 4 sale60,000$1.2M100.0%UnusualSEC
Aug 3, 2015Aug 5, 2015Epizyme, Inc.President & CEOForm 4 sale60,000$1.3M100.0%UnusualSEC
Jul 6, 2015Jul 8, 2015Epizyme, Inc.President & CEOForm 4 sale60,000$1.4M100.0%UnusualSEC
Nov 3, 2014Nov 4, 2014Epizyme, Inc.President & CEOForm 4 sale30,000$749k100.0%UnusualSEC
Oct 1, 2014Oct 3, 2014Epizyme, Inc.President & CEOForm 4 sale30,000$788k100.0%UnusualSEC
Sep 2, 2014Sep 4, 2014Epizyme, Inc.CEOForm 4 sale30,000$1M100.0%UnusualSEC
Aug 1, 2014Aug 5, 2014Epizyme, Inc.CEOForm 4 sale30,000$907k100.0%UnusualSEC
Jul 1, 2014Jul 3, 2014Epizyme, Inc.CEOForm 4 sale30,000$946k100.0%UnusualSEC
Jun 2, 2014Jun 4, 2014Epizyme, Inc.CEOForm 4 sale30,000$666k100.0%UnusualSEC
May 1, 2014May 5, 2014Epizyme, Inc.CEOForm 4 sale30,000$657k100.0%UnusualSEC
Apr 7, 2014Apr 8, 2014Epizyme, Inc.CEOForm 4 sale30,000$607k100.0%UnusualSEC
Feb 10, 2014Feb 12, 2014Epizyme, Inc.CEOForm 4 sale60,000$1.8M100.0%UnusualSEC
Jan 2, 2014Jan 6, 2014Epizyme, Inc.President and CEOForm 4 sale30,000$605k100.0%UnusualSEC